Friday, July 10, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase I Pipeline Programs

First-in-human and early clinical safety studies in Phase I.

Programs 4,713
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.

Top sponsors

Pipeline programs

Page 81 of 99

  1. TAK-114 10 mg capsule

    Takeda

    Clinical Pharmacology

    phase 1 small molecule completed

    1 trial

  2. TAK-117

    Takeda

    Metastatic Solid Tumors

    phase 1 small molecule completed

    1 trial

  3. TAK-117

    Takeda

    Neoplasm, Advanced or Metastatic

    phase 1 small molecule completed

    1 trial

  4. TAK-123

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  5. TAK-137

    Takeda

    Attention-Deficit/Hyperactivity Disorder

    phase 1 small molecule terminated

    1 trial

  6. TAK-137

    Takeda

    Dose Finding Study

    phase 1 small molecule completed

    1 trial

  7. TAK-137 5 mg tablet, TAK-137 placebo tablet

    Takeda

    Healthy Japanese Adult Male

    phase 1 small molecule terminated

    1 trial

  8. TAK-164

    Takeda

    Gastrointestinal Neoplasms; Esophageal, Stomach, Pancreas, Colon Neoplasms; Malignant Tumors of Digestive Organ; Advanced Gastrointestinal Malignancies

    phase 1 small molecule terminated

    1 trial

  9. TAK-165

    Takeda

    Breast Neoplasm

    phase 1 small molecule completed

    1 trial

  10. TAK-227

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  11. TAK-228

    Takeda

    Advanced Nonhematologic Malignancies

    phase 1 small molecule completed

    1 trial

  12. TAK-233

    Takeda

    Clinical Pharmacology

    phase 1 small molecule completed

    1 trial

  13. TAK-272

    Takeda

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  14. TAK-272

    Takeda

    Japanese Healthy Adult Males

    phase 1 small molecule completed

    1 trial

  15. TAK-279

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    3 trials

  16. TAK-279

    Takeda

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  17. TAK-279

    Takeda

    Renal Impairment

    phase 1 small molecule completed

    1 trial

  18. TAK-329

    Takeda

    Type 1 Diabetes Mellitus

    phase 1 small molecule completed

    1 trial

  19. TAK-385

    Takeda

    Hormone Treatment-naïve Participants With Prostate Cancer

    phase 1 small molecule completed

    1 trial

  20. TAK-385 40 mg

    Takeda

    Japanese Premenopausal Healthy Adult Women

    phase 1 small molecule completed

    1 trial

  21. TAK-385 T2 Formulation

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  22. TAK-418

    Takeda

    Healthy Volunteers

    phase 1 small molecule terminated

    2 trials

  23. TAK-418

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  24. TAK-438

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  25. TAK-438

    Takeda

    Dose Finding Study

    phase 1 small molecule completed

    2 trials

  26. TAK-438

    Takeda

    Erosive Esophagitis(EE)

    phase 1 small molecule completed

    1 trial

  27. TAK-438

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  28. TAK-438

    Takeda

    Ascending Single Dose Study

    phase 1 small molecule completed

    1 trial

  29. TAK-438 OD

    Takeda

    Japanese Healthy Adult Male

    phase 1 small molecule completed

    1 trial

  30. TAK-438ASA

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  31. TAK-491

    Takeda

    Healthy Volunteer

    phase 1 small molecule completed

    1 trial

  32. TAK-510

    Takeda

    Healthy Participants

    phase 1 small molecule completed

    1 trial

  33. TAK-536

    Takeda

    Japanese Healthy Adult Male Participants

    phase 1 small molecule completed

    1 trial

  34. TAK-536

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  35. TAK-536 Tablet

    Takeda

    Japanese Healthy Adult Males

    phase 1 small molecule completed

    1 trial

  36. TAK-536TCH

    Takeda

    Hypertension

    phase 1 small molecule completed

    1 trial

  37. TAK-573

    Teva Pharma GmbH

    Relapsed and/or Refractory Multiple Myeloma

    phase 1 small molecule terminated

    1 trial

  38. TAK-580

    Takeda

    Melanoma

    phase 1 small molecule terminated

    1 trial

  39. TAK-648

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  40. TAK-648

    Takeda

    Type 2 Diabetes Mellitus

    phase 1 small molecule completed

    1 trial

  41. TAK-648 Tablet

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  42. TAK-653

    NEUROCRINE BIOSCIENCES INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  43. TAK-653 Placebo

    NEUROCRINE BIOSCIENCES INC

    Depressive Disorder

    phase 1 small molecule completed

    1 trial

  44. TAK-659

    Takeda

    Lymphoma, Non-Hodgkin

    phase 1 small molecule terminated

    1 trial

  45. TAK-659

    Nektar Therapeutics UK Limited

    Lymphoma, Non-Hodgkin

    phase 1 small molecule terminated

    1 trial

  46. TAK-671

    Takeda

    Coronavirus Disease

    phase 1 small molecule terminated

    1 trial

  47. TAK-676

    Takeda

    Head and Neck Squamous Cell Carcinoma

    phase 1 small molecule completed

    1 trial

  48. TAK-755

    Takeda

    Sickle Cell Disease

    phase 1 small molecule completed

    1 trial

Frequently asked questions

How many Phase I pipeline programs are in the directory?

4,713 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.